Effect of postmenopausal hormone replacement therapy on cardiovascular performance

Maturitas

Volumn 47, Issue 2, 2004, Pages 107-113

  Özdemir, Kurtulus ^a   Çelik, Çetin ^a   Altunkeser, Bülent B ^a   Içli, Abdullah ^a   Albeni, Havva ^a   Düzenli, Akif ^a   Akyürek, Cemalettin ^a   Gök, Hasan ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Echocardiography; Exercise test; Hormone replacement therapy; Menopause

Indexed keywords

CONJUGATED ESTROGEN; HORMONE; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; CARDIOVASCULAR PERFORMANCE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; EXERCISE; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PERFORMANCE; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; LONG TERM CARE; NORMAL HUMAN; POSTMENOPAUSE; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE;

EID: 1642522075     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(03)00248-2     Document Type: Article

References (40)

1. Staessen J.A., Ginocchio G., Thijs L., Fagard R. Conventional and ambulatory blood pressure and menopause in a prospective population study. J. Hum. Hypertens. 11:1997;507-514.
2. Schillaci G., Verdecchia P., Borgioni C., Ciucci A., Porcellati C. Early cardiac changes after menopause. Hypertension. 32:1998;764-769.
3. Bush T.L. The epidemiology of cardiovascular disease in postmenopausal women. Ann. New York Acad. Sci. 592:1990;263-271.
4. Rosenberg L., Hennekens C.H., Rosner B., Belanger C., Rothman K.J., Speirer F.E. Early menopause and the risk of myocardial infarction. Am. J. Obstet. Gynecol. 139:1981;47-51.
5. Petitti D.B., Perlman J.A., Sidney S. Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek study. Obstet. Gynecol. 70:1987;289-293.
6. Teede H.J., Liang Y.L., Shiel L.M., McNeil J.J., McGrath B.P. Hormone replacement therapy in postmenopausal women protects against smoking-induced changes in vascular structure and function. J. Am. Coll. Cardiol. 34:1999;131-137.
7. Reis S.E., Holubkov R., Young J.B., White B.G., Cohn J.N., Feldman A.M. Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies. J. Am. Coll. Cardiol. 36:2000;529-533.
8. Butkevich A., Carmella A., Phillips R.A. Hormone replacement therapy and 24-h blood pressure profile of postmenopausal women. Am. J. Hypertens. 13:2000;1039-1041.
9. Kamali P., Müller T., Lang U., Clapp J.F. Cardiovascular responses of perimenopausal women to hormonal replacement therapy. Am. J. Obstet. Gynecol. 182:2000;17-22.
10. Herdersen B.E., Paganini-HILL A., Ross R.K. Decreased mortality in users of estrogen replacement therapy. Arch. Intern. Med. 151:1991;75-78.
11. Grady D., Rubin S.M., Petitti D.B., Fox C.S., Black D., Ettinger B., et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 117:1992;1016-1037.
12. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. J. Am. Med. Assoc. 275:1996;370-375.
13. Pacifici R., Brown C., Puscheck E., et al. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc. Natl. Acad. Sci. 66:1991;5134-5138.
14. Ammann P., Rizzoli R., Bonjour J.P., et al. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J. Clin. Invest. 99:1997;1699-1703.
15. Sudhir K., Chou T.M., Mullen W.L., et al. Mechanisms of estrogen-induced vasodilatation: in vivo studies in canine coronary conductance and resistance arteries. J. Am. Coll. Cardiol. 26:1995;807-814.
16. Lang U., Baker S., Clark K.E. Estrogen induced increases in coronary blood flow are antagonized by inhibitors of nitric oxide synthesis. Eur. J. Obstet. Gynecol. Reprod. Biol. 74:1997;229-235.
17. Grady D., Herrington D., Bittner V. Cardiovascular disease outcomes during 6.8 years of hormone therapy. J. Am. Med. Assoc. 288:2002;49-57.
18. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initative randomized controlled trial. J. Am. Med. Assoc. 288:2002;321-333.
19. Tei C., Ling L.H., Hodge D.O., Bailey K.R., Oh J.K., Rodeheffer R.J., et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function: a study in normal and dilated cardiomyopathy. J. Cardiol. 26:1995;357-366.
20. Hayward C.S., Kelly R.P., Collins P. The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc. Res. 46:2000;28-49.
21. Nelson H.D., Humphrey L.L., Nygren P., Teutsch S.M., Allan J.D. Postmenopausal hormone replacement therapy. J. Am. Med. Assoc. 288:2002;872-881.
22. Grodstein F., Samfer M.J., Golditz G.A., et al. Postmenopausal hormone replacement therapy and mortality. New Engl. J. Med. 336:1997;1769-1775.
23. Rosano G.M.C., Sarrel P.M., Poole-Wilson P.A., Collins P. Beneficial effect of estrogen on exercise-induced myocardial ischemia in women with coronary artery disease. Lancet. 342:1993;133-136.
24. Voutilainen S., Hippelainen M., Hulkko S., Karpinen K., Ventila M., Kupari M. Left ventricular diastolic function by Doppler echocardiography in relation to hormonal replacemnet therapy in healthy postmenopausal women. Am. J. Cardiol. 71:1993;614-617.
25. Taskin O., Gokdeniz R., Muderrisoglu H., Korkmaz M.E., Uryan I., Atmaca R., Kafkasli A. The effects of hormone replacement therapy on echocardiographic basic cardiac functions in postmenopausal women. Hum. Reprod. 13:1998;2399-2401.
26. Yildirir A., Yarali H., Aybar F., Akgül E., Bukulmez O. Hormone replacement therapy to improve left ventricular diastolic functions in healthy postmenopausal women. Int. J. Gynaecol. Obstet. 75:2001;273-278.
27. Gallinelli A., Angioni S., Matteo M.L., Montaldo P.L., Fenu M.A., Volpe A. Variations of cardiac performance and inotropism in healthy postmenopausal women treated with estroprogestin replacement therapy. Menopause. 6:1999;49-55.
28. Fisman E.Z., Tenenbaum A., Shapira I., Motro M., Pines A. The acute effects of sublingual estradiol on left ventricular diastolic function in normotensive and hypertensive postmenopausal women. Maturitas. 33:1999;145-152.
29. Leonardo F., Medeirus C., Rosano G.M.C., Pereira W.I., Sheiban I., Gebara O., Bellotti G., Pileggi F., Chierchia S.L. Effect of acute administration of estradiol 17 beta on aortic blood flow in menopausal women. Am. J. Cardiol. 80:1997;791-793.
30. Mercuro G., Zoncu S., Paoletti A.M., Melis G.B., Vacca A.M.B., Cherchi A. Study of myocardial contractility by pulsed wave Doppler tissue imaging does not reveal an inotropic effect of estrogen at physiologic dose. Am. J. Cardiol. 83:1999;1677-1679.
31. Snabes M.C., Payne J.P., Kopelen H.A., Dunn J.K., Zoghbi W.A. Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women: a randomized, double blind, placebo controlled, crossover trial. Obstet. Gynecol. 89:1997;332-339.
32. Tei C., Dujardin K.S., Hodge D.O., Kyle R.A., Tajik A.J., Seward J.B. Doppler MPI combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J. Am. Coll. Cardiol. 27:1996;658-664.
33. Yeo T.C., Dujardin K.S., Tei C., Mahoney D.W., McGoon M.D., Seward J.B. Value of a Doppler-derived MPI combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. Am. J. Cardiol. 81:1998;1157-1161.
34. Dujardin K.S., Tei C., Yeo T.C., Hodge D.O., Rossi A., Seward J.B. Prognostic value of a Doppler MPI combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy. Am. J. Cardiol. 82:1998;1071-1076.
35. Barrett-Connor E., Wilcosky T., Wallace R.B., Heiss G. Resting and exercise electrocardiographic abnormalities associated with sex hormone use in women. Am. J. Epidemiol. 123:1986;81-88.
36. Cerquetani E., Leonardo F., Pagnotta P., et al. Anti-ischemic effect of chronic oestrogen replacement therapy alone or in combination with medroxyprogesterone acetate in different replacement schemes. Maturitas. 39:2001;245-251.
37. Lee M., Giardina E.G.V., Homma S., DiTullio M.R., Sciacca R.R. Lack of effect of estrogen on rest and treadmill exercise in postmenopausal women without known cardiac disease. Am. J. Cardiol. 80:1997;793-797.
38. Jiang C., Poole-Wilson P.A., Sarrel P.M., Mochizuki S., Collins P., MacLeod K.T. Effect of 17β-estradiol on contraction, Ca 21 current and intracellular free Ca 21 in guinea-pig isolated cardiac myocytes. Br. J. Pharmacol. 106:1992;739-745.
39. Gisclard V., Flavahan N.A., Vanhoutte P.M. Alpha adrenergic responses of blood vessels of rabbits after ovariectomy and administration of 17β-estradiol. Pharmacol. Exp. Ther. 240:1987;466-470.
40. Chang W.C., Nakao J., Orimo H., Murota S.I. Stimulation of prostacyclin biosynthetic activity by estradiol in rat aortic smooth muscle cells. Biochem. Biophys. Acta. 619:1980;107-118.